Title:
経粘膜投与薬剤
Document Type and Number:
Japanese Patent JP7355326
Kind Code:
B2
Abstract:
Provided is a pharmaceutical agent for enhancing absorption efficiency of a drug through the mucosal epithelial layer. A pharmaceutical agent for transmucosal administration comprises as an active ingredient a drug compound to which a podocalyxin targeting molecule is bound.
Inventors:
Shogo Misumi
Naoki Kishimoto
Ryotaro Mimata
Naoki Kishimoto
Ryotaro Mimata
Application Number:
JP2019143948A
Publication Date:
October 03, 2023
Filing Date:
August 05, 2019
Export Citation:
Assignee:
Denka Company Limited
Kumamoto University, a national university corporation
Kumamoto University, a national university corporation
International Classes:
A61K47/68; A61K31/745; A61K45/00; A61P1/04; A61P3/00; A61P3/06; A61P3/10; A61P5/00; A61P9/00; A61P9/06; A61P9/10; A61P9/12; A61P11/06; A61P11/08; A61P11/10; A61P11/14; A61P13/02; A61P19/10; A61P21/02; A61P23/00; A61P25/04; A61P25/06; A61P25/08; A61P25/16; A61P25/18; A61P25/20; A61P25/22; A61P25/24; A61P25/28; A61P29/00; A61P29/02; A61P31/04; A61P31/12; A61P33/00; A61P37/04; A61P37/06; A61P37/08
Domestic Patent References:
| JP2019512548A | ||||
| JP2018538356A |
Attorney, Agent or Firm:
Arga Patent Office
Previous Patent: Cell lineage generation method, program, and cell lineage generation device
Next Patent: handheld nutrunner
Next Patent: handheld nutrunner